Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen

References 

1. Moller-Jensen O, Estève J, Moller H, Renard H. Cancer in the European Community and its member states. Eur. J. Cancer. 1990;26:1167–1256
   • MEDLINE
2. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma in the extremes of age (a comparison of patients younger than 35 years and older than 75 years). J. Surg. Oncol. 1985;28:90–96
   • MEDLINE
   • CrossRef
3. Fisher CJ, Egan MK, Smith P, et al.  Histopathology in relation to age. Br. J. Cancer. 1997;75:593–596
   • MEDLINE
4. Greenfield S, Blanco DM, Elashoff RM, et al.  Patterns of care related to age of breast cancer patients. JAMA. 1987;257:2766–2770
   • MEDLINE
5. Newschaffer CJ, Penberthy L, Desch CE, et al.  The effect of age and comorbidity in the treatment of elderly women with non-metastatic breast cancer. Arch. Intern. Med. 1996;156:85–90
   • MEDLINE
6. Preece PE, Wood RAB, Mackie CA, et al.  Tamoxifen as initial sole treatment of localised breast cancer in elderly women (a pilot study). Br. Med. J. 1982;284:869–870
7. Allan SG, Rodger A, Smyth JF, et al.  Tamoxifen as primary treatment in elderly or frail patients (a practical management). Br. Med. J. 1985;290:358
8. Bradbeer JW. Treatment of primary breast cancer with Nolvadex alone. Rev. Endocr. Rel. Cancer. 1985;(Suppl. 17):77–80
9. Rose C, Thorpe SM, Mouridsen HT, et al.  Antioestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Res. Treat. 1983;3:77–84
   • MEDLINE
   • CrossRef
10. Com-Nougue C, Rodary C, Patte C. How to establish equivalence when data are censored (a randomised trial of treatments for B non-Hodgkin's lymphoma). Statistics in Medicine. 1993;12:1353–1364
    • MEDLINE
    • CrossRef
11. Early Breast Cancer Trialists' Collaborative Group . Tamoxifen for early breast cancer (an overview of the randomised trials). Lancet. 1998;351:1451–1467
    • Abstract
    • Full Text
    • Full-Text PDF (643 KB)
    • CrossRef
12. Gazet J-C, Markopoulos C, Ford HT, et al.  Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Lancet. 1988;I:679–681
13. Robertson JFR, Todd JH, Ellis IO, et al.  Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. Br. Med. J. 1988;297:311–314
14. Bates T, Riley DL, Houghton J, et al.  Breast cancer in elderly women (a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone). Br. J. Surg. 1991;78:591–594
    • MEDLINE
    • CrossRef
15. Fentiman IS. Breast cancer, tamoxifen and surgery. Lancet. 1988;I:1044
16. Gazet J-C, Ford HT, Coombes RC, et al.  Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Eur. J. Surg. Oncol. 1994;20:207–214
    • MEDLINE
17. Robertson JFR, Ellis IO, Elston CW, Blamey RW. Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients (5 year follow-up). Eur. J. Cancer. 1992;28A:908–910
    • MEDLINE
18. Kenny FS, Robertson JFR, Ellis IO, et al.  Long-term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. The Breast. 1998;7:335–339
19. Bates T, Fennessy M, Riley DJ, Baum M, Houghton J. Breast cancer in the elderly: surgery improves survival. The results of the Cancer Research Campaign Trial. Eur. J. Cancer 2001, 37 Suppl. 5.
20. Mustacchi G, Milani S, Pluchinotta A, et al.  Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer (the GRETA Trial). Anticancer Res. 1994;14:197–200
21. Gaskell DJ, Hawkins RA, Sangster K, Chetty U, Forrest APM. Relationship between immunohistochemical estimation of oestrogen receptors in elderly patients with primary operable breast cancer in response to tamoxifen. Lancet. 1989;I:1044–1046